Loading…
A novel EGR2 mutation within a family with a mild demyelinating form of Charcot-Marie-Tooth disease
Mutations of the early growth response 2 (EGR2) gene have been reported in a variety of severe demyelinating neuropathies such as autosomal recessive congenital hypomyelinating neuropathy, autosomal dominant child‐onset Dejerine‐Sottas neuropathy, and autosomal dominant adult‐onset Charcot‐Marie‐Too...
Saved in:
Published in: | Journal of the peripheral nervous system 2012-06, Vol.17 (2), p.206-209 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Mutations of the early growth response 2 (EGR2) gene have been reported in a variety of severe demyelinating neuropathies such as autosomal recessive congenital hypomyelinating neuropathy, autosomal dominant child‐onset Dejerine‐Sottas neuropathy, and autosomal dominant adult‐onset Charcot‐Marie‐Tooth disease (CMT). Here, we report on a heterozygous mutation in EGR2 (c.1160C>A), which results in threonine at position 387 being changed to asparagine, in a family with a mild demyelinating form of adult‐onset CMT. Of note, both the proband and her asymptomatic son exhibited neither pes cavus nor champagne‐bottle leg atrophy, suggesting that the heterozygous T387N mutation may result in a relatively mild phenotype of demyelinating CMT. |
---|---|
ISSN: | 1085-9489 1529-8027 |
DOI: | 10.1111/j.1529-8027.2012.00403.x |